A microcosting study of intensive care unit stay in the Netherlands
- PMID: 18508839
- DOI: 10.1177/0885066608318661
A microcosting study of intensive care unit stay in the Netherlands
Abstract
The primary objective of this study was to estimate the actual daily costs of intensive care unit stay using a microcosting methodology. As a secondary objective, the degree of association between daily intensive care unit costs and some patient characteristics was examined. This multicenter, retrospective cost analysis was conducted in the medical-surgical adult intensive care units of 1 university and 2 general hospitals in the Netherlands for 2006, from a hospital perspective. A total of 576 adult patients were included, consuming a total of 2868 nursing days. The mean total costs per intensive care unit day were 1911, with labour (33%) and indirect costs (33%) as the most important cost drivers. An ordinary least squares analysis including age, Nine Equivalent of Nursing Manpower Use score/Therapeutic Intervention Scoring System score, mechanical ventilation, blood products, and renal replacement therapy was able to predict 50% of the daily intensive care unit costs.
Similar articles
-
[Treatment costs in a medical intensive care unit: a comparison of 1992 and 1997].Dtsch Med Wochenschr. 1998 Jun 5;123(23):719-25. doi: 10.1055/s-2007-1024044. Dtsch Med Wochenschr. 1998. PMID: 9651569 German.
-
Growth of intensive care unit resource use and its estimated cost in Medicare.Crit Care Med. 2008 Sep;36(9):2504-10. doi: 10.1097/CCM.0b013e318183ef84. Crit Care Med. 2008. PMID: 18679127
-
Cost savings attributable to reductions in intensive care unit length of stay for mechanically ventilated patients.Med Care. 2008 Dec;46(12):1226-33. doi: 10.1097/MLR.0b013e31817d9342. Med Care. 2008. PMID: 19300312
-
Intensive care unit mortality trends in children after hematopoietic stem cell transplantation: a meta-regression analysis.Crit Care Med. 2008 Oct;36(10):2898-904. doi: 10.1097/CCM.0b013e318186a34a. Crit Care Med. 2008. PMID: 18766109 Review.
-
Monitoring costs in the ICU: a search for a pertinent methodology.Acta Anaesthesiol Scand. 2012 Oct;56(9):1104-13. doi: 10.1111/j.1399-6576.2012.02735.x. Acta Anaesthesiol Scand. 2012. PMID: 22967197 Review.
Cited by
-
Cost-consequence analysis of remifentanil-based analgo-sedation vs. conventional analgesia and sedation for patients on mechanical ventilation in the Netherlands.Crit Care. 2010;14(6):R195. doi: 10.1186/cc9313. Epub 2010 Nov 1. Crit Care. 2010. PMID: 21040558 Free PMC article. Clinical Trial.
-
Economics of ICU organization and management.Crit Care Clin. 2012 Jan;28(1):25-37, v. doi: 10.1016/j.ccc.2011.09.004. Epub 2011 Oct 22. Crit Care Clin. 2012. PMID: 22123097 Free PMC article. Review.
-
Real-world cost-effectiveness of oxaliplatin in stage III colon cancer: a synthesis of clinical trial and daily practice evidence.Pharmacoeconomics. 2013 Aug;31(8):703-18. doi: 10.1007/s40273-013-0061-6. Pharmacoeconomics. 2013. PMID: 23657918 Clinical Trial.
-
Real-world cost-effectiveness of cetuximab in locally advanced squamous cell carcinoma of the head and neck.Eur Arch Otorhinolaryngol. 2015 Aug;272(8):2007-16. doi: 10.1007/s00405-014-3106-3. Epub 2014 Jun 19. Eur Arch Otorhinolaryngol. 2015. PMID: 24943191
-
Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands.Eur Arch Otorhinolaryngol. 2016 Feb;273(2):455-64. doi: 10.1007/s00405-015-3495-y. Epub 2015 Jan 21. Eur Arch Otorhinolaryngol. 2016. PMID: 25876000 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials